APPLE ROBERT F (President & CEO) received a stock award from ANTARES PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2022ACC: 0001016169-22-000035
DirectorOfficer· President & CEO
Since Aug 2018
+49.12K
Net shares
Net buyer
$143.2K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
86.81K acquired · 37.70K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+86.81K
Price / share
—
Trade value
—
% of position
3.6%
3/3/2022
2.44M→2.53M
Common Stock
Direct
Shares
−37.70K
Price / share
$3.80
Trade value
$143.24K
% of position
1.5%
3/3/2022
2.53M→2.49M
Total
Net shares
+49.12K
Net value
-$143.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2022 | A · Award | +86.81K | — | — | 3.6% | 2.44M | 2.53M |
| Common Stock Direct | 3/3/2022 | F · Tax Withholding | −37.70K | $3.80 | $143.24K | 1.5% | 2.53M | 2.49M |
| Total | +49.12K | -$143.24K | ||||||
Derivative Transactions0
No derivative transactions reported